Wed, Sep 17, 2014, 1:09 PM EDT - U.S. Markets close in 2 hrs 51 mins

Recent

% | $
Quotes you view appear here for quick access.

Chelsea Therapeutics Internatio Message Board

  • millersbox millersbox Jan 29, 2013 12:48 PM Flag

    Any real holders with actual talk - not bashing or saling other #$%$

    Holder of some shares and looking for some insight, not bashing or trollers. I think they still have a shot and will get the nice bounce to at least 3 in my book - any thoughts.

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I have been waiting also. Bought shortly after the plunge, averaged down to 92 cents thinking they should recover some also. Not into message boards here as there is alot of spam and junk. They have a product that works..shame on the FDA.

      • 1 Reply to jaxson370
      • Yeah there are some real investors around here..not many though. Here's the deal with Chelsea. The FDA wants longer term efficacy data than has been provided with the Phase 3's to this point. 306b which released results in December was not statistically significant when it came to long term data but the trial wasn't originally designed with that in mind.

        Chelsea will meet with the FDA at some point in the next few months to design a new Phase 3 trial to meet the FDA requirement. I think depending on how that meeting goes can be a catalyst for the stock to get it moving in a positive direction again..meaning if Chelsea's management can convince investors that they've designed a trial that they believe can meet the FDAs requirement.

        Besides that, they have a cash issue that will need to be addressed at some point this year.

 
CHTP
6.520.00(0.00%)Jun 23 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.